Lisa Gill
Stock Analyst at JP Morgan
(3.47)
# 819
Out of 4,826 analysts
134
Total ratings
51.16%
Success rate
2.55%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DGX Quest Diagnostics | Maintains: Neutral | $180 → $190 | $177.57 | +7.00% | 3 | May 6, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $652 → $525 | $404.81 | +29.69% | 6 | Apr 24, 2025 | |
| CON Concentra Group Holdings Parent | Maintains: Overweight | $29 → $30 | $21.59 | +38.95% | 2 | Mar 19, 2025 | |
| OPCH Option Care Health | Maintains: Overweight | $40 → $41 | $32.81 | +24.96% | 4 | Mar 6, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $14 → $17 | $15.48 | +9.82% | 4 | Mar 6, 2025 | |
| HUM Humana | Maintains: Neutral | $257 → $256 | $256.69 | -0.27% | 6 | Feb 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $80 → $81 | $67.10 | +20.72% | 5 | Feb 18, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $142 → $145 | $151.99 | -4.60% | 6 | Feb 4, 2025 | |
| COR Cencora | Maintains: Overweight | $289 → $301 | $291.97 | +3.09% | 2 | Jan 24, 2025 | |
| PACS PACS Group | Downgrades: Neutral | $18 | $10.08 | +78.57% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $2.89 | +73.01% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $23.47 | +19.30% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $27 → $28 | $22.96 | +21.95% | 4 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $15 | $11.00 | +36.36% | 14 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $7.15 | +25.87% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $22 → $18 | $8.18 | +120.05% | 4 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $656 → $661 | $707.00 | -6.51% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $438 | $333.01 | +31.53% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $13.17 | +36.67% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $319.63 | +23.58% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $246.82 | -1.55% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $178.19 | +4.38% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $149.03 | -6.06% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $349.38 | -4.97% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $628 → $631 | $416.30 | +51.57% | 4 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.69 | +113.22% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $4.12 | +118.45% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $4.74 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $6.62 | +20.85% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $66.58 | +24.66% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $59.78 | +63.93% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $20.51 | - | 4 | Dec 19, 2017 |
Quest Diagnostics
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $177.57
Upside: +7.00%
UnitedHealth Group
Apr 24, 2025
Maintains: Overweight
Price Target: $652 → $525
Current: $404.81
Upside: +29.69%
Concentra Group Holdings Parent
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $21.59
Upside: +38.95%
Option Care Health
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $32.81
Upside: +24.96%
Alignment Healthcare
Mar 6, 2025
Maintains: Neutral
Price Target: $14 → $17
Current: $15.48
Upside: +9.82%
Humana
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $256.69
Upside: -0.27%
CVS Health
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $67.10
Upside: +20.72%
Cardinal Health
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $151.99
Upside: -4.60%
Cencora
Jan 24, 2025
Maintains: Overweight
Price Target: $289 → $301
Current: $291.97
Upside: +3.09%
PACS Group
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $10.08
Upside: +78.57%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $2.89
Upside: +73.01%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $23.47
Upside: +19.30%
Nov 29, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $22.96
Upside: +21.95%
Aug 30, 2024
Maintains: Overweight
Price Target: $20 → $15
Current: $11.00
Upside: +36.36%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $7.15
Upside: +25.87%
Aug 21, 2024
Maintains: Underweight
Price Target: $22 → $18
Current: $8.18
Upside: +120.05%
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $707.00
Upside: -6.51%
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $333.01
Upside: +31.53%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $13.17
Upside: +36.67%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $319.63
Upside: +23.58%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $246.82
Upside: -1.55%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $178.19
Upside: +4.38%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $149.03
Upside: -6.06%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $349.38
Upside: -4.97%
May 30, 2024
Maintains: Overweight
Price Target: $628 → $631
Current: $416.30
Upside: +51.57%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.69
Upside: +113.22%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $4.12
Upside: +118.45%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $4.74
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $6.62
Upside: +20.85%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $66.58
Upside: +24.66%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $59.78
Upside: +63.93%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $20.51
Upside: -